| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Akihiro Nishimura | Q91829537 |
| Tetsuro Kobayashi | Q91829541 | ||
| P2093 | author name string | Shota Kikuno | |
| Yasumichi Mori | |||
| Minoru Okubo | |||
| Kimio Matsumura | |||
| Kaoru Nagasawa | |||
| P2860 | cites work | High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes: response to Buzzetti et al | Q81509295 |
| Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes | Q82436990 | ||
| Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations | Q82521460 | ||
| Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population | Q83076345 | ||
| Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity | Q83147116 | ||
| Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset | Q84668994 | ||
| Evaluating peripheral nerve function in asymptomatic patients with type 2 diabetes or latent autoimmune diabetes of adults (LADA): results from nerve conduction studies | Q86081124 | ||
| C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study | Q86982817 | ||
| HLA Genetic Discrepancy Between Latent Autoimmune Diabetes in Adults and Type 1 Diabetes: LADA China Study No. 6 | Q87270548 | ||
| 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019 | Q90595498 | ||
| 13. Children and Adolescents: Standards of Medical Care in Diabetes-2019 | Q90595539 | ||
| Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM) | Q90856452 | ||
| Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in Japan | Q90856759 | ||
| Interventions for latent autoimmune diabetes (LADA) in adults | Q24234365 | ||
| The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study | Q28253729 | ||
| Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study | Q30414984 | ||
| Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. | Q30538087 | ||
| Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trøndelag Health Study | Q33556625 | ||
| Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. | Q33556707 | ||
| Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes | Q33601181 | ||
| Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus | Q33628681 | ||
| Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways | Q33930280 | ||
| Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years | Q34084609 | ||
| Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: a population-based cross-sectional study | Q34422172 | ||
| Type 1 diabetes and autoimmunity | Q34451284 | ||
| Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment | Q34469916 | ||
| An association analysis of the HLA gene region in latent autoimmune diabetes in adults. | Q34790072 | ||
| Genetic analysis of adult-onset autoimmune diabetes | Q35227229 | ||
| Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells. | Q35641422 | ||
| Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement | Q35740110 | ||
| Latent autoimmune diabetes in adults (LADA) should be less latent | Q36271849 | ||
| Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults | Q36666059 | ||
| Immunomodulation for the prevention of SPIDDM and LADA. | Q36666070 | ||
| Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals | Q36783114 | ||
| Diabetes classification: grey zones, sound and smoke: Action LADA 1. | Q37212028 | ||
| Mortality in adult-onset autoimmune diabetes is associated with poor glycemic control: results from the HUNT Study | Q37331257 | ||
| Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy | Q38071010 | ||
| Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment | Q38615808 | ||
| Clinical heterogeneity of type 1 diabetes (T1D) found in Asia. | Q38679002 | ||
| Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). | Q38697919 | ||
| Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus | Q39292286 | ||
| IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). | Q40438269 | ||
| Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA). | Q40524112 | ||
| Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM--the clinical characteristics and pathogenesis of the syndrome | Q40595823 | ||
| High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). | Q41742171 | ||
| Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study | Q41762781 | ||
| Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S). | Q42371744 | ||
| Pancreatic ductal hyperplasia/dysplasia with obstructive chronic pancreatitis: an association with reduced pancreatic weight in type 1 diabetes | Q42544224 | ||
| Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study | Q42637921 | ||
| Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. | Q42984414 | ||
| Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor | Q43073078 | ||
| Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study | Q44508079 | ||
| Residual β-Cell Function and HLA-A24 in IDDM: Markers of Glycemic Control and Subsequent Development of Diabetic Retinopathy | Q44581658 | ||
| Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes | Q44616498 | ||
| Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe | Q45161315 | ||
| Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. | Q45242512 | ||
| Pioglitazone might prevent the progression of slowly progressive type 1 diabetes. | Q45969709 | ||
| Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus | Q46656831 | ||
| The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus | Q46660693 | ||
| Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. | Q46708957 | ||
| Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes | Q46725882 | ||
| Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese | Q46933199 | ||
| Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. | Q46960670 | ||
| Adult-onset autoimmune diabetes: current knowledge and implications for management | Q47694295 | ||
| Analysis of Pancreatic Volume in Acute-Onset, Slowly-Progressive and Fulminant Type 1 Diabetes in a Japanese Population. | Q50087859 | ||
| T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report | Q77216611 | ||
| Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes | Q79886788 | ||
| Higher body mass index in adults at diagnosis of the slowly progressive form of type 1 diabetes mellitus is associated with lower risk HLA genes | Q50474912 | ||
| Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes. | Q50975018 | ||
| Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. | Q51034393 | ||
| Relationship between HLA haplotype and BMI change in Japanese slowly progressive type 1 diabetes patients. | Q51175510 | ||
| Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). | Q51313824 | ||
| GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). | Q51320193 | ||
| Slowly progressive type 1 diabetes treated with metformin for five years after onset. | Q51330642 | ||
| Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. | Q51370364 | ||
| The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea. | Q51388988 | ||
| High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. | Q51474390 | ||
| Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). | Q51561147 | ||
| Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. | Q51561850 | ||
| Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. | Q51565693 | ||
| Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas. | Q51600739 | ||
| Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay. | Q51614567 | ||
| Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12. | Q52721463 | ||
| Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). | Q53969854 | ||
| The diagnosis of insulitis in human type 1 diabetes. | Q55057348 | ||
| Latent Autoimmune Diabetes in Adults: Current Status and New Horizons. | Q55397117 | ||
| Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group | Q56901621 | ||
| The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan | Q56902324 | ||
| Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes | Q56904461 | ||
| CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults | Q56904522 | ||
| CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry | Q56908161 | ||
| A Global Perspective of Latent Autoimmune Diabetes in Adults | Q57166316 | ||
| Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome | Q57228323 | ||
| Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes | Q57365327 | ||
| First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes | Q58065034 | ||
| UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes | Q58678933 | ||
| Distinct Inflammatory Changes of the Pancreas of Slowly Progressive Insulin-dependent (Type 1) Diabetes | Q58761291 | ||
| Detection of Insulitis By Pancreatic Scintigraphy With99mTc-Labelled-IL2 and MRI in Patients With LADA (Action LADA 10) | Q61478307 | ||
| Tyrosine Phosphatase–Related Islet Antigen 2(256–760)Autoantibodies, the Only Marker of Islet Autoimmunity That Increases by Increasing the Degree of BMI in Obese Subjects With Type 2 Diabetes | Q61478312 | ||
| Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes | Q68935165 | ||
| Maleness as risk factor for slowly progressive IDDM | Q69499568 | ||
| Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies | Q71150178 | ||
| Slowly progressive IDDM and malnutrition-related diabetes | Q71287001 | ||
| GAD antibodies seldom disappear in slowly progressive IDDM | Q71694265 | ||
| Relationships among residual β cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus | Q72077287 | ||
| Immunogenetic and clinical characterization of slowly progressive IDDM | Q72219250 | ||
| Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus | Q73351587 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 2461-2477 | |
| P577 | publication date | 2019-11-28 | |
| P1433 | published in | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Q5270108 |
| P1476 | title | Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives | |
| P478 | volume | 12 |
| Q99725238 | Enteroviruses and Type 1 Diabetes Mellitus: An Overlooked Relationship in Some Regions | cites work | P2860 |
Search more.